Browse > Article

Overproduction of Recombinant Human VEGF (Vascular Endothelial Growth Factor) in Chinese Hamster Ovary Cells  

Lee, Seong-Baek (PanGen Biotech Inc.)
Park, Jeong-Soo (PanGen Biotech Inc.)
Lee, Seung-Hee (PanGen Biotech Inc.)
Park, Jun-Ho (PanGen Biotech Inc.)
Yu, Sung-Ryul (Graduate School of Biotechnology, Kyung Hee University)
Kim, Hee-Chan (Graduate School of Biotechnology, Kyung Hee University)
Kim, Dong-Jun (PanGen Biotech Inc.)
Byun, Tae-Ho (PanGen Biotech Inc.)
Baek, Kwang-Hee (Graduate School of Biotechnology, Kyung Hee University)
Ahn, Young-Joon (School of Agricultural Biotechnology, Seoul National University)
Yoon, Jae-Seung (Graduate School of Biotechnology, Kyung Hee University)
Publication Information
Journal of Microbiology and Biotechnology / v.18, no.1, 2008 , pp. 183-187 More about this Journal
Abstract
Vascular endothelial growth factors (VEGFs) are a family of proteins that mediate angiogenesis. $VEGF_{165}$ is a VEGF-A isoform and has been extensively studied owing to its potential use in therapeutic angiogenesis. This study established Chinese hamster ovary (CHO) cells overexpressing recombinant human $VEGF_{165}$ $(rhVEGF_{165})$ protein. The production rate of the established CHO cells was over 80mg/l of $rhVEGF_{165}$ protein from a 7-day batch culture process using a 7.5-l bioreactor with a 5-l working volume and serum-free medium. The $rhVEGF_{165}$ protein was purified to homogeneity from the culture supernatant using a two-step chromatographic procedure that resulted in a 48% recovery rate. The purified $rhVEGF_{165}$ protein was a glycosylated homodimeric protein with a higher molecular weight (MW) than the protein expressed from insect cells, suggesting that the glycosylation of the $rhVEGF_{165}$ protein in CHO cells differed from that in insect cells. The purified $rhVEGF_{165}$ protein in this study was functionally active with a half-maximal effective concentration of 3.8ng/ml and specific activity of $2.5{\times}10^5U/mg$.
Keywords
VEGF; Chinese hamster ovary (CHO) cell; recombinant protein expression; stable cell line; bioreactor process;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
Times Cited By Web Of Science : 2  (Related Records In Web of Science)
연도 인용수 순위
1 Carmeliet, P. 2003. Angiogenesis in health and disease. Nat. Med. 9: 653-660   DOI   ScienceOn
2 Ciudad, C. J., G. Urlaub, and L. A. Chasin. 1988. Deletion analysis of the Chinese hamster dihydrofolate reductase gene promoter. J. Biol. Chem. 263: 16274-16282
3 Ferrara, N. 2004. Vascular endothelial growth factor: Basic science and clinical progress. Endocrine Rev. 25: 581-611   DOI   ScienceOn
4 Henry, T. D., B. H. Annex, G. R. McKendall, M. A. Azrin, J. J. Lopez, F. J. Giordano, P. K. Shah, J. T. Willerson, R. L. Benza, D. S. Berman, C. M. Gibson, A. Bajamonde, A. C. Rundle, E. R. McCluskey; VIVA Investigators. 2003. The VIVA trials: Vascular endothelial growth factor in ischemia for vascular angiogenesis. Circulation 107: 1359-1365   DOI   ScienceOn
5 Keyt, B. A., L. T. Berleau, H. V. Nguyen, H. Chen, H. Heinsohn, R. Vandlen, and N. Ferrara. 1996. The carboxylterminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency. J. Biol. Chem. 271: 7788-7795   DOI
6 Siemeister, G., B. Schnurr, K. Mohrs, C. Schachtele, D. Marme, and G. Martiny-Baron. 1996. Expression of biologically active isoforms of the tumor angiogenesis factor VEGF in Escherichia coli. Biochem. Biophys. Res. Commun. 222: 249-255   DOI   ScienceOn
7 Plouet, J., F. Moro, S. Bertagnolli, N. Coldeboeuf, H. Mazarguil, S. Clamens, and F. Bayard. 1997. Extracellular cleavage of the vascular endothelial growth factor 189-amino acid form by urokinase is required for its mitogenic effect. J. Biol. Chem. 272: 13390-13396   DOI   ScienceOn
8 Bhisitkul, R. B. 2006. Vascular endothelial growth factor biology: Clinical implications for ocular treatments. Br. J. Ophthalmol. 90: 1542-1547   DOI   ScienceOn
9 Kozak, M. 1984. Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs. Nucleic Acids Res. 4: 857-872
10 Park, J., S. Yu, J. Yoon, and K. Baek. 2005. High-level expression of recombinant human bone morphogenetic protein- 4 in Chinese hamster ovary cells. J. Microbiol. Biotechnol. 15: 1397-1401   과학기술학회마을
11 Freedman, S. B. 2002. Clinical trials of gene therapy for atherosclerotic cardiovascular disease. Curr. Opin. Lipidol. 13: 653-661   DOI   ScienceOn
12 Ferrara, N., H.-P. Gerber, and J. LeCouter. 2003. The biology of VEGF and its receptors. Nat. Med. 9: 669-676   DOI   ScienceOn
13 Grabenhorst, E., P. Schlenke, S. Pohl, M. Nimtz, and H. S. Conradt. 1999. Genetic engineering of recombinant glycoproteins and the glycosylation pathway in mammalian host cells. Glycoconjugate J. 16: 81-97   DOI   ScienceOn
14 Risau, W. 1997. Mechnisms of angiogenesis. Nature 386: 671- 674   DOI   ScienceOn
15 Bae, G. W., D.-W. Jeong, H. J. Kim, G. M. Lee, H. Park, T.-B. Choe, S. Kang, I. Y. Kim, and I.-H. Kim. 2006. High productivity of t-PA in CHO cells using hypoxia response element. J. Microbiol. Biotechnol. 16: 695-703   과학기술학회마을
16 Byun, J., J. M. Heard, J. E. Huh, S. J. Park, E. A. Jung, J. O. Jeong, H. C. Gwon, and D. K. Kim. 2001. Efficient expression of the vascular endothelial growth factor gene in vitro and in vivo, using an adeno-associated virus vector. J. Mol. Cell Cardiol. 33: 295-305   DOI   ScienceOn
17 Kim, E., D. Kim, H.-Y. Hwang, J. Yoon, Y. Yoon, and K. Baek. 2004. High-level expression of recombinant human interleukin- 2 in Chinese hamster ovary cells using the expression system containing transcription terminator. J. Microbiol. Biotechnol. 14:810-815
18 Yang, R., S. Bunting, A. Ko, B. A. Keyt, N. B. Modi, T. F. Zioncheck, N. Ferrara, and H. Jin. 1998. Substantially attenuated hemodynamic responses to Escherichia coli-derived vascular endothelial growth factor given by intravenous infusion compared with bolus injection. J. Pharmacol. Exp. Ther. 284: 103-110
19 Lee, G. Y., W. W. Jung, C. S. Kang, and I. S. Bang. 2006. Expression and characterization of human endothelial growth factor (VEGF165) in insect cells. Protein Expr. Purif. 46: 503-509   DOI   ScienceOn
20 Kim, J.-M., J.-S. Kim, D.-H. Park, H. S. Kang, J. Yoon, K. Baek, and Y. Yoon. 2004. Improved recombinant gene expression in CHO cells using matrix attachment regions. J. Biotechnol. 107: 95-105   DOI   ScienceOn
21 Mohanraj, D., T. Olson, and S. Ramakrishnan. 1995. Expression of biologically active human vascular endothelial growth factor in yeast. Growth Factors 12: 17-27   DOI   ScienceOn
22 Tammela, T., B. Enholm, K. Alitalo, and K. Paavonen. 2005. The biology of vascular endothelial growth factors. Cardiovasc. Res. 65: 550-563   DOI   ScienceOn
23 Ferrara, N. 2002. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: Therapeutic implication. Semin. Oncol. 29: 10-14
24 Folkman, J. 1995. Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nat. Med. 1: 27-31   DOI   ScienceOn
25 Yamazaki, Y. and T. Morita. 2006. Molecular and functional diversity of vascular endothelial factors. Mol. Divers. 10: 515-527   DOI   ScienceOn
26 Na, K. H., S. C. Kim, K. S. Seo, S. H. Lee, W. B. Kim, and K. C. Lee. 2005. Purification and characterization of recombinant human follicle stimulating hormone produced by Chinese hamster ovary cells. J. Microbiol. Biotechnol. 15: 395-402   과학기술학회마을
27 Kastrup, J., E. Jorgensen, A. Ruck, K. Tagil, D. Glogar, W. Ruzyllo, H. E. Botker, D. Dudek, V. Drvota, B. Hesse, L. Thuesen, P. Blomberg, M. Gyongyosi, C. Sylven; Euroinject One Group. 2005. Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patient with stable severe angina pectoris. J. Am. Coll. Cardiol. 45: 982-988   DOI   ScienceOn
28 Conn, G., D. D. Soderman, M. T. Schaeffer, M. Wile, V. B. Hatcher, and K. A. Thomas. 1990. Purification of glycoprotein vascular endothelial cell mitogen from rat glioma-derived cell line. Proc. Natl. Acad. Sci. USA 87: 1323-1327